spacer
home > pmps > summer 2017 > industry insight
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

Industry Insight

Our everyday lives are becoming dependent on smart phones and ‘cloud’ technologies. My sons (both in their early 20s) are constantly on their iPhones, trawling social media, gaming or taking ‘selfies’. Ironically, mobile phones are used more for managing our lives than for audible communication. On them, we can book flights and remotely change the central heating setting in our homes. This is the age we now live in, whether we like it or not. The ‘Internet of Things’ (IoT) is infiltrating every facet of our personal and working lives. Even the pharmaceutical industry – historically very conservative in its practices and slow to change – is moving with the times.

In this edition, Eva Weber at ABBYY Europe gives a vision of the factory of the future, where she predicts we will see greater integration of robotics with optical recognition systems throughout the manufacturing chain (page 22). Jeff Hackney and Mike Boudreaux at Emerson also describe how the IoT is influencing practices relating to data management within the healthcare industries – both in the production sectors and for the design of medical devices (page 61).

Data integrity is vitally important within pharma. Articles from Piritta Maunu at Vaisala (page 18) and Léon van Deurse at Chemgineering (page 40) provide insights into the current practices for ensuring IT security and information integrity for computerised systems, introducing the soon-to-become-familiar acronyms of GAMP 5, ITIL and COBIT.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Robert Harris is Chief Technical Officer at Juniper Pharma Services and PMPS Industry Advisor.
Print this page
Send to a friend
Privacy statement
News and Press Releases

Merck to Provide Provantage® End-to-End Development and Manufacturing Services to Y-mAbs for Lead Antibody Compound


More info >>

White Papers

Running Better Trials Taking an Intelligent Monitoring Approach

Bioclinica

When it comes to implementing a risk-based monitoring program, it is not just about reducing monitoring visits and doing less Source Document Verification (SDV). It’s about bringing together your people, a solid process, and the right technology to run a better trial. Success with risk-based monitoring requires the ability to make sense of the thousands, if not millions, of data points captured by multiple disparate sources in a clinical trial. With the sheer volume of data generated on a daily basis comes complexity. How does one make sense of it all? Information overload burdens even the most experienced study teams who struggle to understand which data matters most and what it means.
More info >>

 
Industry Events

Pharma and Device Packaging and Labeling West Coast 2017

28-29 November 2017, Burlingame, California

Following a very successful launch year, we are thrilled to announce that Pharma and Device Packaging and Labeling will be returning to the West Coast for our 2nd annual event.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement